Serina Therapeutics, Inc.

NYSEAM:SER Stock Report

Market Cap: US$49.1m

Serina Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Steve Ledger

Chief executive officer

US$237.5k

Total compensation

CEO salary percentage71.6%
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Steve Ledger's remuneration changed compared to Serina Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$7m

Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$11m

Dec 31 2023US$238kUS$170k

US$5m

Compensation vs Market: Steve's total compensation ($USD237.50K) is below average for companies of similar size in the US market ($USD650.00K).

Compensation vs Earnings: Insufficient data to compare Steve's compensation with company performance.

CEO

Steve Ledger (65 yo)

less than a year

Tenure

US$237,500

Compensation

Mr. Steven A. Ledger, also known as Steve, was the Founder of Tamalpais Partners LLC and served as its Managing Partner since January 2009 until 2012. Mr. Ledger has experience as an investor in emerging t...

Leadership Team

NamePositionTenureCompensationOwnership
Steven Ledger
CEO & Directorless than a yearUS$237.50kno data
Randall Moreadith
Chief Development Officerno dataUS$433.88k0%
$ 0
Balkrishan Gill
Executive Chairmanless than a yearno data0%
$ 0
Srini Tenjarla
Senior Vice President of Chemistryless than a yearno datano data

0.7yrs

Average Tenure

65yo

Average Age

Experienced Management: SER's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Steven Ledger
CEO & Directorless than a yearUS$237.50kno data
Balkrishan Gill
Executive Chairmanless than a yearno data0%
$ 0
William Schmidt
Member of Scientific Advisory Boardno datano datano data
Gregory Bailey
Independent Directorless than a yearno data0.72%
$ 351.7k
J. Harris
Directorless than a yearno data0%
$ 0
Steven Mintz
Independent Directorless than a yearno data0.41%
$ 199.9k
Richard Marshall
Independent Directorless than a yearno datano data
Remy Gross
Independent Directorless than a yearno data0%
$ 0
Gaurav Sahay
Member of Scientific Advisory Boardno datano datano data

0.8yrs

Average Tenure

62yo

Average Age

Experienced Board: SER's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 16:09
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Serina Therapeutics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution